| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Perspective Therapeutics, Inc. | VP Finance/Prin Fin&Acct Offic | Common stock | 84K | $30.3K | $0.36 | Apr 23, 2024 | Direct |
| Perspective Therapeutics, Inc. | VP Finance/Prin Fin&Acct Offic | Stock Option (right to buy) | 34.5K | Jul 17, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| CATX | Perspective Therapeutics, Inc. | Jul 17, 2024 | 1 | $0 | 4 | Jul 19, 2024 | VP Finance/Prin Fin&Acct Offic |
| CATX | Perspective Therapeutics, Inc. | Apr 23, 2024 | 2 | $10.8K | 4 | Apr 24, 2024 | VP Finance/Prin Fin&Acct Offic |
| CATX | Perspective Therapeutics, Inc. | Jun 12, 2023 | 1 | $0 | 4 | Jun 14, 2023 | VP Finance/Prin Fin&Acct Offic |
| CATX | Isoray, Inc. | Aug 9, 2022 | 1 | $0 | 4 | Aug 11, 2022 | VP Finance/Prin Fin&Acct Offic |
| CATX | Isoray, Inc. | Jun 8, 2022 | 2 | $5.38K | 4 | Jun 9, 2022 | VP Finance/Prin Fin&Acct Offic |
| CATX | Isoray, Inc. | Jul 1, 2021 | 1 | $0 | 4 | Jul 6, 2021 | Controller/Prin Fin&Acct Offic |